Levy Harkins & Co’s Precigen PGEN Stock Holding History

Levy Harkins & Co’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-272,137	Closed	-$9.14M	–	20
2016 Q1	$9.14M	Buy	+272,137	New	+$8.57M	3.88%	11

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Levy Harkins & Co's PGEN Position: Q2 2016 in Review

Levy Harkins & Co sold out of Precigen (PGEN) in Q2 2016, closing a stake of 272,137 shares — an estimated $9.14M sold.

Levy Harkins & Co first reported a position in PGEN in Q1 2016 and held it in 1 quarter. The position peaked at $9.14M in Q1 2016. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

Levy Harkins & Co reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
Levy Harkins & Co sold 272,137 Precigen shares in Q2 2016, an estimated $9.14M.
Levy Harkins & Co first reported a position in Precigen in Q1 2016 and held it in 1 quarter.
Levy Harkins & Co's Precigen position peaked at $9.14M in Q1 2016.
169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Levy Harkins & Co's 13F filing for Q2 2016, filed 14 Jul 2016.